Walgreens Statement on Mifepristone
06 Março 2023 - 8:53PM
Business Wire
We want to be very clear about what our position has always
been: Walgreens plans to dispense Mifepristone in any jurisdiction
where it is legally permissible to do so. Once we are certified by
the FDA, we will dispense this medication consistent with federal
and state laws. Providing legally approved medications to patients
is what pharmacies do, and is rooted in our commitment to the
communities in which we operate.
About Walgreens
Walgreens (www.walgreens.com) is included in the United States
segment of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an
integrated healthcare, pharmacy and retail leader serving millions
of customers and patients every day, with a 170-year heritage of
caring for communities. As America’s most loved pharmacy, health
and beauty company, Walgreens purpose is to champion the health and
well-being of every community in America. Operating nearly 9,000
retail locations across America, Puerto Rico and the U.S. Virgin
Islands, Walgreens is proud to be a neighborhood health destination
serving approximately 9 million customers each day. Walgreens
pharmacists play a critical role in the U.S. healthcare system by
providing a wide range of pharmacy and healthcare services. To best
meet the needs of customers and patients, Walgreens offers a true
omnichannel experience, with fully integrated physical and digital
platforms supported by the latest technology to deliver
high-quality products and services in local communities
nationwide.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230306005859/en/
Jim Cohn Walgreens Boots Alliance Media Relations
Jim.cohn@wba.com
Walgreens Boots Alliance (NASDAQ:WBA)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024